Retroperitoneal germ cell tumor diagnosed by endoscopic ultrasound-guided fine needle aspiration

Tekijä Womeldorph, Craig M, Zalupski, Mark M, Knoepp, Stewart M, Soltani, Mohammad, Elmunzer, B Joseph
Julkaistu 2010

Using (18)F Fluorodeoxyglucose Positron Emission Tomography (FDG PET) to Monitor Clinical Outcomes in Patients Treated with Neoadjuvant Chemo-Radiotherapy for Locally Advanced Panc...

Tekijä Choi, Minsig, Heilbrun, Lance K., Venkatramanamoorthy, Raghu, Lawhorn-Crews, Jawana M., Zalupski, Mark M., Shields, Anthony F.
Julkaistu 2010

A phase II study of biweekly cisplatin, fixed dose rate gemcitabine and infusional 5-fluorouracil in patients with metastatic pancreatic and biliary cancers

Tekijä Davis, Elizabeth J., Griffith, Kent A., Kim, Edward J., Ruch, Joshua M., McDonnell, Kevin J., Zalupski, Mark M.
Julkaisussa Am J Clin Oncol (2018)

CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy

Tekijä HAMMAD, Nazik, HEILBRUN, Lance K, PHILIP, Philip A, SHIELDS, Anthony F, ZALUPSKI, Mark M, VENKATRAMANAMOORTHY, Raghu, EL-RAYES, Bassel F
Julkaistu 2010

A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancer

Tekijä Gartner, Elaina M., Griffith, Kent A., Pan, Quintin, Brewer, George J., Henja, Gwen F., Merajver, Sofia D., Zalupski, Mark M.
Julkaistu 2008

DEPTOR has growth suppression activity against pancreatic cancer cells

Tekijä Li, Hua, Sun, Grace Y., Zhao, Yongchao, Thomas, Dafydd, Greenson, Joel K., Zalupski, Mark M., Ben-Josef, Edgar, Sun, Yi
Julkaisussa Oncotarget (2014)

Neoadjuvant Stereotactic Body Radiation Therapy (SBRT), Capecitabine, and Liver Transplantation for Unresectable Hilar Cholangiocarcinoma

Tekijä Welling, Theodore H., Feng, Mary, Wan, Shanshan, Hwang, Sin Ye, Volk, Michael L., Lawrence, Theodore S., Zalupski, Mark M., Sonnenday, Christopher J.
Julkaistu 2013

SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy

Tekijä Davis, Elizabeth J., Zhao, Lili, Lucas, David R., Schuetze, Scott M., Baker, Laurence H., Zalupski, Mark M., Thomas, Dafydd, Chugh, Rashmi
Julkaisussa BMC Cancer (2016)

Prognostic Significance of Carbohydrate Antigen 19-9 in Unresectable Locally Advanced Pancreatic Cancer Treated With Dose-Escalated Intensity Modulated Radiation Therapy and Concur...

Tekijä Vainshtein, Jeffrey M., Schipper, Matthew, Zalupski, Mark M., Lawrence, Theodore S., Abrams, Ross, Francis, Isaac R., Khan, Gazala, Leslie, William, Ben-Josef, Edgar
Julkaistu 2012

Carbohydrate Antigen 19-9 Is a Prognostic and Predictive Biomarker in Patients With Advanced Pancreatic Cancer Who Receive Gemcitabine-Containing Chemotherapy: A Pooled Analysis of...

Tekijä Bauer, Todd M., El-Rayes, Bassel F., Li, Xiaobai, Hammad, Nazik, Philip, Philip A., Shields, Anthony F., Zalupski, Mark M., Bekaii-Saab, Tanios
Julkaisussa Cancer (2012)

Prognostic Value of c-MET Expression in Patients With Pancreatic Cancer Receiving Adjuvant and Neoadjuvant Chemoradiation Therapy

Tekijä Cuneo, Kyle C., Morgan, Meredith A., Griffith, Kent A., Hawkins, Peter G., Greenson, Joel K., Ben-Josef, Edgar, Lawrence, Theodore S., Zalupski, Mark M.
Julkaisussa Int J Radiat Oncol Biol Phys (2017)

Original Article A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer

Tekijä Cohen, Steven J., Zalupski, Mark M., Modiano, Manuel R., Conkling, Paul, Patt, Yehuda Z., Davis, Peg, Dorr, Robert T., Boytim, Michelle L., Hersh, Evan M.
Julkaistu 2009

A Phase I Trial of Cabozantinib and Gemcitabine in Advanced Pancreatic Cancer

Tekijä Zhen, David B, Griffith, Kent A, Ruch, Joshua M, Camphausen, Kevin, Savage, Jason E, Kim, Edward J, Sahai, Vaibhav, Simeone, Diane M, Zalupski, Mark M
Julkaisussa Invest New Drugs (2016)

Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma: A Phase 2 Clinical Trial

Tekijä Sahai, Vaibhav, Catalano, Paul J., Zalupski, Mark M., Lubner, Sam Joseph, Menge, Mark R., Nimeiri, Halla Sayed, Munshi, Hidayatullah G., Benson, Al Bowen, O’Dwyer, Peter J.
Julkaisussa JAMA Oncol (2018)

Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancer

Tekijä El-Rayes, Bassel F., Zalupski, Mark M., Manza, Stephanie G., Rusin, Barbara, Ferris, Ann Marie, Vaishampayan, Ulka, Heilbrun, Lance K., Venkatramanamoorthy, Raghu, Shields, Anthony F., Philip, Philip A.
Julkaistu 2007

Quality of life in a prospective multi-center phase II trial of neoadjuvant full dose gemcitabine, oxaliplatin and radiation in patients with resectable or borderline resectable pa...

Tekijä Serrano, Pablo E., Herman, Joseph M., Griffith, Kent A., Zalupski, Mark M, Kim, Edward J., Bekaii-Saab, Tanios S., Ben-Josef, Edgar, Dawson, Laura A., Ringash, Jolie, Wei, Alice C.
Julkaisussa Int J Radiat Oncol Biol Phys (2014)

Phase 2 Trial of Neoadjuvant FOLFIRINOX and Intensity Modulated Radiation Therapy Concurrent With Fixed-Dose Rate-Gemcitabine in Patients With Borderline Resectable Pancreatic Canc...

Tekijä Tran, Nguyen H., Sahai, Vaibhav, Griffith, Kent A., Nathan, Hari, Kaza, Ravi, Cuneo, Kyle C., Shi, Jiaqi, Kim, Edward, Sonnenday, Christopher J., Cho, Clifford S., Lawrence, Theodore S., Zalupski, Mark M.
Julkaisussa Int J Radiat Oncol Biol Phys (2019)

A phase I/II trial of intensity-modulated radiation (IMRT) dose escalation with concurrent fixed- dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer

Tekijä Ben-Josef, Edgar, Schipper, Mathew, Francis, Isaac R, Hadley, Scott, Ten-Haken, Randall, Lawrence, Theodore, Normolle, Daniel, Simeone, Diane M., Sonnenday, Christopher, Abrams, Ross, Leslie, William, Khan, Gazala, Zalupski, Mark M.
Julkaistu 2012

The Quality-of-Life Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer

Tekijä Herman, Joseph M., Narang, Amol K., Griffith, Kent A., Zalupski, Mark M., Reese, Jennifer B., Gearhart, Susan L., Azad, Nolifer S., Chan, June, Olsen, Leah, Efron, Jonathan E., Lawrence, Theodore S., Ben-Josef, Edgar
Julkaistu 2012

Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

Tekijä Kim, Edward J., Sahai, Vaibhav, Abel, Ethan V., Griffith, Kent A., Greenson, Joel K., Takebe, Naoko, Khan, Gazala N., Blau, John L., Craig, Ronald, Balis, Ulysses G., Zalupski, Mark M., Simeone, Diane M.
Julkaisussa Clin Cancer Res (2014)